As California ends Medicaid coverage for GLP-1 weight loss drugs like Wegovy and Zepbound, experts say the state's advice to ...

MEDVi, a telehealth platform serving more than 100,000 patients, today announced an expanded physician-led program ...

Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...

New analysis adds to existing evidence that Omada’s program paired with GLP-1 medications leads to greater weight loss and persistence than reported in real world evidenceSAN FRANCISCO, Jan. 08, 2026 ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

As of Jan. 1, 2026, CenCal Health and all other Medi-Cal managed care plans will no longer cover the cost of GLP-1 weight loss medications such as Wegovy and Zepbound due to policy changes by Medi-Cal ...

By reinforcing exercise, health care providers can ensure that GLP-1 therapy leads to weight loss, sustains muscle mass, and ...

Suddenly, we’re people who wake up early, drink green things, and believe this will be the year everything clicks. By ...

When HCA Healthcare, one of the largest hospital systems in the U.S., recently told employees it would stop covering blockbuster obesity drugs Zepbound and Wegovy next year, it pointed them to an ...

Weight loss drugs have shown impressive short-term results, but new research suggests their benefits may be difficult to ...